STAT+: Physicians rally to avert Medicare payment cuts
The federal government is officially reducing Medicare payments to physicians next year by 4.5%, but…
Category: Congress
.jpg)
Missouri Senate race shows just how hard it is to campaign on abortion in the heartland
KANSAS CITY, Mo. – If any Senate race should be a referendum on abortion access…
With Republicans on the verge of congressional control, science is on the line
WASHINGTON — In this year’s midterms, the future of federal science policy is in Republicans’…
STAT+: Republican ideas to reform Medicare could rile health care industry
WASHINGTON — Democrats are suddenly blasting Republicans on the campaign trail over a surprising new…
For experts on stroke, Fetterman-Oz debate is a teachable moment
At a Senate debate Tuesday, the Pennsylvania Democrat John Fetterman, who is recovering from a…
STAT+: Q&A: A health justice lawyer and new MacArthur ‘genius’ on pharma’s patent games
Priti Krishtel has had it with the patent tricks up pharma’s sleeves. The co-executive director…
On the campaign trail, Republicans ramp up anti-science, anti-Covid, often anti-Fauci messaging
WASHINGTON — Even as the pandemic fades from our daily lives, it is at the…
Medicare is going to cap patients’ spending on drugs. But there’s no such limit for hospital or doctor bills
By 2025, people on Medicare who take expensive medications will feel significant financial relief: They…
STAT+: Despite its threats, PhRMA is still supporting Democrats who voted for Medicare negotiation
Drugmakers’ powerhouse lobby did not exactly make good on its early August threat to hold…
STAT+: Lawmakers push NIH to disclose steps being taken to ensure clinical trial results are reported
A group of Republican senators is demanding to know what steps the U.S. National Institutes…
After tough period for lobby, BIO chief Michelle McMurry-Heath goes on leave
WASHINGTON — Michelle McMurry-Heath, one of the most prominent faces of the drug industry in Washington,…
The U.S. is terrible at keeping businesses from worsening public health, experts say
WASHINGTON – Here in the U.S., it’s “in” to study the social determinants of health….
STAT+: Medicare lays out the bureaucracy it will need to negotiate drug prices
WASHINGTON — New documents obtained by STAT outline how Medicare is planning to build out…
Health funding battles, a nutrition policy overhaul, and two CBD developments
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Democrats concede to clean user fee agreement to fund FDA
WASHINGTON — Democrats have conceded to Republican demands and agreed to fund the Food and…
STAT+: White House pitches drug pricing reforms as a way to extend cancer patients’ lives
WASHINGTON — The White House is pitching an added benefit to Democrats’ recent drug pricing…
Coors, Mondelez, and other big food companies want to sell CBD-filled food and drinks. The FDA is staunchly opposed
WASHINGTON — Major food makers are ready to cash in on selling CBD-filled foods and…
House Democrat presses bill to encourage more diversity in clinical trials run by NIH
Rep. Robin Kelly admits that the word “diversity” has scared some of her Republican colleagues…
.jpg)
STAT+: Patients for Affordable Drugs taps new leader
WASHINGTON — One of Washington’s most prominent drug pricing patient groups is tapping an advocate who…
STAT+: Lawmaker requests investigation into HCA over billing practices
WASHINGTON — A Democratic House lawmaker with oversight authority is calling for an investigation into the…
STAT+: FDA funding negotiations heat up ahead of September deadline
WASHINGTON — Negotiations are intensifying over massive, multibillion-dollar legislation to fund the Food and Drug…
Opinion: Congress should not compel Medicare to pay for liquid biopsies
When the two Republican senators from Mississippi cosponsor legislation with the two Democratic senators from…
What Fauci’s exit tells us about the ongoing fight against Covid
There was a time when Anthony Fauci thought he would retire when the Covid-19 pandemic…
STAT+: Hospitals wrangle billions in FEMA funding to offset Covid costs
More hospitals are tapping into billions of dollars from the Federal Emergency Management Agency to…
Opinion: Organ transplantation is at a crossroads. Major reform is needed
In early August, the Senate Finance Committee held a bipartisan hearing co-chaired by Senators Ron…
STAT+: Pharma’s likely to sue over Medicare negotiation. Here are the arguments they might use
WASHINGTON — Democrats finally achieved a win over the pharmaceutical industry this month when they…
STAT+: Unpacking the drug pricing policies that Congress just approved
WASHINGTON — Medicare coverage for prescription drugs will look very different when President Biden signs…
Private equity’s latest fixation & the ACA subsidy spigot
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Cancer patient who devoted six years to drug pricing reform isn’t done yet
BETHESDA, Md. — After six years of relentless advocacy work, David Mitchell was finally on…
In a momentous vote for Pelosi, House sends drug pricing reforms to President Biden’s desk
WASHINGTON — Fifteen years later, House Speaker Nancy Pelosi is fulfilling one of her first campaign…
STAT+: Wyden wants details on Amgen’s U.S. taxes as part of expanding probe into pharma practices
The head of the U.S. Senate Finance Committee is seeking details from Amgen about the…
Democrats’ TGIF moment, pathologists defend their turf, & Biogen’s back at the FDA’s doorstep
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Here’s who Democrats’ drug pricing bill will actually help
WASHINGTON — Millions of patients in the Medicare program could eventually see lower prescription drug costs…
STAT+: The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended consequences
There’s really no ignoring the inexorable math that led the Senate to approve a plan…
A lobbying frenzy over surprise billing, employer dialysis questions, and a big broker throwdown
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
In a massive victory for Democrats, Medicare is poised to negotiate drug prices
WASHINGTON — President Biden is on the verge of his own crowning health care achievement…
Democrats dramatically narrow their ambitions for lowering insulin costs
WASHINGTON — Democrats’ high hopes to lower insulin costs for patients with insurance got downsized on…
Democrats will have to limit their drug pricing reforms to Medicare to comply with Senate rules
WASHINGTON — Democrats will likely have to axe two provisions from their drug pricing plan…
The glaring health equity gap in Democrats’ drug pricing plan
WASHINGTON — As Democrats close in on the biggest overhaul of the Medicare prescription drug…
Listen: The last-minute push for drug pricing reform, Alnylam’s success, and Sarepta’s gamble
Is drug pricing reform really happening this time? Are things finally turning around for biotech?…
A chaotic sprint to lower insulin prices and AIDS activists go after Biden on monkeypox
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Opinion: Keeping climate provisions in the budget reconciliation act is a key step toward protecting Americans’ health
Last week’s surprise agreement between Sen. Joe Manchin (D-W.Va.) and Senate Majority Leader Chuck Schumer…
The view on drug pricing from Wall Street, a pharma-friendly Dem holds firm, and what’s next for a big telehealth bill
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Wyden says Merck and Abbott aren’t cooperating with probe into pharma tax practices
In his ongoing quest to probe pharmaceutical industry tax practices, the head of the U.S….
Senators demand answers about federal prisons’ scant use of Covid therapeutics
WASHINGTON — Fourteen senators are demanding that the federal Bureau of Prisons explain its scant…
STAT+: ‘What can we do?’: Pharma lobbyists face their biggest test in a decade, as Democrats barrel toward a vote on drug pricing
WASHINGTON — The pharmaceutical industry, notorious for its deep pockets and aggressive lobbying tactics, has a…
Opinion: Drug price controls are a dance with the devil: short-term savings will be overwhelmed by loss of innovation
Democrats have sent the legislative text of a sweeping proposal for drug price controls to…
Powerful Senate Democrat outlines ‘plenty’ more drug pricing reforms to follow Medicare negotiation
WASHINGTON — Democrats may be closer than ever to passing sweeping drug pricing reforms, but…
Virtual Event: Democrats’ Last Chance for Drug Pricing Reform?
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
PhRMA and BIO descend on D.C. & unpacking the Senate’s FDA funding drama
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…